检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:孔一慧[1] 张颖[1] 李娜[1] 张莉[1] 高艳辉[1] 薛红杰[1] 李悦[1] 李为民[1]
机构地区:[1]哈尔滨医科大学附属第一医院心内科,150001
出 处:《中华心血管病杂志》2010年第5期435-439,共5页Chinese Journal of Cardiology
基 金:基金项目:黑龙江省科技厅国际合作项目(WB07C01);黑龙江省教育厅资助项目(11531108);黑龙江省博士后启动基金(LRB04.242);哈尔滨医科大学附属第一医院基金资助项目(2007106)
摘 要:目的 研究心力衰竭(心衰)大鼠心肌β3,肾上腺素能受体(β3-AR)变化,观察选择性β3-AR抑制剂(SR59230A)对β3-AR、氧化应激状态的影响.方法 将异丙肾上腺素(ISO)诱导的心衰大鼠随机分成ISO组(18只)与ISO+SR59230A组(21只),同时以正常大鼠为对照组(7只).ISO+SR59230A组给予SR59230A,每日2次腹腔注射;ISO组给予相应生理盐水1 ml;对照组不予处置.6周后测定心功能、心肌β3-AR、内皮型一氧化氮合酶(eNOS)、小三磷酸鸟苷结合蛋白(Racl)mRNA、蛋白表达及脂质过氧化物(LPO)、总超氧化物歧化酶(T-SOD)指标.结果 心衰大鼠心功能恶化,心肌β3-AR mRNA表达增加,SR59230A可改善心功能,降低β3-AR mRNA表达(均为P〈0.05).心衰时,eNOS、Racl mRNA及蛋白上调,LPO产生增加、T-SOD水平降低.SR59230A降低eNOS、Racl表达,增加心肌组织T-SOD水平,使LPO减少(均为P〈0.05).结论 心衰时,β3-AR表达增加,加重心肌氧化应激反应,恶化心功能.β3-AR抑制剂改善心功能可能通过抑制氧化应激、延缓心衰进展来实现.Objective To investigate the association between β3-adrenergic receptor (β3-AR) and oxidative stress in isoproterenol (ISO)-induced chronic heart failure (HF) rats. Methods Seven weight-matched normal adult rats (control), 18 ISO induced heart failure rats and 21 ISO induced heart failure rats treated with specific (β3-AR inhibitor, SR59230A for 6 weeks were included in this study. Echocardiography was performed at the end of the study and the myocardial levels of total superoxide dismutase (T-SOD) and lipid peroxidation (LPO) were measured by colorimetry, myocardial expression of (β3-AR was detected by reverse transcription-polymerase chain reaction ( RT-PCR). Result Compared with control group, the cardiac function was significantly reduced and myocardial β3-AR mRNA expression was significantly increased, LPO level was also significantly enhanced while T-SOD level was significantly reduced in ISO group and these changes could be significantly attenuated by treatment with SR59230A Conclusion Our results showed that myocardial upregulation of β3-AR is associated with increased oxidative stress in this model and β3-AR inhibitor may be a new therapeutic agent for heart failure treatment
分 类 号:R541.6[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.80